You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《亞洲市況》日經半日續升89點 藥廠衛採挫8.8%
阿思達克 12-23 11:05
美國白宮恢復與參議員Joe Manchin就開支法案的談判,市場對新冠變種Omicron憂慮減低,均支持大市,美股三大指數隔晚升0.7%至1.2%。日經指數承接過去兩日升勢,今早(23日)高開140點後,早市升幅略收窄,半日收升89點或0.31%,報28,651。美元兌日圓報114.13。 主要金融股普遍小幅造好,三菱日聯、瑞穗、大和、三井住友、Resona控股升0.4%至1.1%、野村則微跌0.8%。權重股分化,迅銷、軟銀集團、Z Holdings跌0.3%至1%、日立跌3.6%、東京電力反覆靠穩,三菱汽車、日產及豐田則升0.5%至1.9%、人力資源公司Recruit Holdings升2.8%。 重工板塊升幅較大,IHI Corp、小鬆製作所、住友重工升2.7%至4.6%。 藥廠衛採挫8.8%,日本衛生專家組指,按現時數據難以評估其與美國Biogen(BIIB.US)合作開發阿茲海默症藥Adulhelm有效性。兩企逾一年前向日本提出新藥上市申請,在6月時已獲美國FDA許可。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account